BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

778 related articles for article (PubMed ID: 17999974)

  • 1. Pneumococcal bacteraemia in Belgium (1994 2004): the pre-conjugate vaccine era.
    Flamaing J; Verhaegen J; Vandeven J; Verbiest N; Peetermans WE
    J Antimicrob Chemother; 2008 Jan; 61(1):143-9. PubMed ID: 17999974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?
    Fenoll A; Aguilar L; Granizo JJ; Giménez MJ; Aragoneses-Fenoll L; Mendez C; Tarragó D
    J Antimicrob Chemother; 2008 Dec; 62(6):1430-3. PubMed ID: 18819966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ; Klugman KP; Pichichero M
    Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003.
    Adegbola RA; Hill PC; Secka O; Ikumapayi UN; Lahai G; Greenwood BM; Corrah T
    Trop Med Int Health; 2006 Jul; 11(7):1128-35. PubMed ID: 16827713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.
    Muñoz-Almagro C; Jordan I; Gene A; Latorre C; Garcia-Garcia JJ; Pallares R
    Clin Infect Dis; 2008 Jan; 46(2):174-82. PubMed ID: 18171247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
    Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states.
    Imöhl M; Reinert RR; van der Linden M
    Int J Med Microbiol; 2010 Apr; 300(4):237-47. PubMed ID: 19604721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptococcus pneumoniae bacteraemia in Belgium: differential characteristics in children and the elderly population and implications for vaccine use.
    Flamaing J; Verhaegen J; Peetermans WE
    J Antimicrob Chemother; 2002 Jul; 50(1):43-50. PubMed ID: 12096005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nationwide surveillance of Streptococcus pneumoniae in Greece: patterns of resistance and serotype epidemiology.
    Poulakou G; Katsarolis I; Matthaiopoulou I; Tsiodras S; Kanavaki S; Hatzaki D; Roilides E; Sofianou D; Kavaliotis I; Kansouzidou A; Kafetzis DA; Paraskakis I; Foustoukou M; Daikos GL; Syriopoulou V; Pangalis A; Leveidiotou S; Giamarellou H;
    Int J Antimicrob Agents; 2007 Jul; 30(1):87-92. PubMed ID: 17540542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media.
    Joloba ML; Windau A; Bajaksouzian S; Appelbaum PC; Hausdorff WP; Jacobs MR
    Clin Infect Dis; 2001 Nov; 33(9):1489-94. PubMed ID: 11588694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: a 10-year study.
    Charfi F; Smaoui H; Kechrid A
    Vaccine; 2012 Dec; 30 Suppl 6():G18-24. PubMed ID: 23228353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000-2006.
    Tyrrell GJ; Lovgren M; Chui N; Minion J; Garg S; Kellner JD; Marrie TJ
    Vaccine; 2009 Jun; 27(27):3553-60. PubMed ID: 19464534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.
    Watson M; Bayley K; Bell JM; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Roche P; Smith HV; Stewart MG; Stylianopoulos J; Turnidge J
    Commun Dis Intell Q Rep; 2003; 27(4):478-87. PubMed ID: 15508501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inferring the potential success of pneumococcal vaccination in Italy: serotypes and antibiotic resistance of Streptococcus pneumoniae isolates from invasive diseases.
    Pantosti A; Boccia D; D'Ambrosio F; Recchia S; Orefici G; Moro ML; ;
    Microb Drug Resist; 2003; 9 Suppl 1():S61-8. PubMed ID: 14633369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotype distribution and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from children in China younger than 5 years.
    Liu Y; Wang H; Chen M; Sun Z; Zhao R; Zhang L; Wang H; Zhang H; Wang L; Chu Y; Liu Y; Ni Y
    Diagn Microbiol Infect Dis; 2008 Jul; 61(3):256-63. PubMed ID: 18358662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory surveillance of invasive pneumococcal disease in Australia, 2003 predicting the future impact of the universal childhood conjugate vaccine program.
    Watson M; Roche P; Bayley K; Bell JM; Collignon P; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Smith HV; Brown M; Stylianopoulos J; Turnidge J
    Commun Dis Intell Q Rep; 2004; 28(4):455-64. PubMed ID: 15745392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotype distribution and antibiotic susceptibility of invasive and nasopharyngeal isolates of Streptococcus pneumoniae among children in rural Mozambique.
    Vallès X; Flannery B; Roca A; Mandomando I; Sigaúque B; Sanz S; Schuchat A; Levine M; Soriano-Gabarró M; Alonso P
    Trop Med Int Health; 2006 Mar; 11(3):358-66. PubMed ID: 16553916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive Streptococcus pneumoniae from Portugal: implications for vaccination and antimicrobial therapy.
    Serrano I; Ramirez M; Melo-Cristino J;
    Clin Microbiol Infect; 2004 Jul; 10(7):652-6. PubMed ID: 15214879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.